Menu

Blog

Jan 7, 2024

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease

Posted by in categories: biotech/medical, neuroscience

In three patients with Alzheimer’s disease, focused ultrasound was applied with aducanumab therapy. Reduction in amyloid was greater in treated regions than in matched contralateral regions over 6 months. Read the full report:


Original Article from The New England Journal of Medicine — Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease.

Comments are closed.